MAL2 and breast carcinoma: Bhandari et al. demonstrated that MAL2 is elevated in breast cancer tissues and that the upregulation of MAL2 was related to the lowest OS rate in the TCGA cohort, suggesting that MAL2 could be an oncogene for breast cancer [52].